Biotech componentsMolecule

Products 31 to 38 of 38

SmartDNA by Applied DNA Sciences
Biotech components: Molecule
Business models: B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Government
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2019/01/30 12:00 (4 years ago)
Known funding amount: 19,800,000 USD
Funding types: Shareholder Investment
Industry: Security
Market status: On the market
Organization type(s): Public Company
Product categories: Forensic Tagging
Production process: Closed Production
Source: NASEM Database
Trading symbol: APDN (NASDAQ)
Value chain stage: Finished Product
SmokeCloak DNA by Applied DNA Sciences
Biotech components: Molecule
Business models: B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2019/02/04 14:40 (4 years ago)
Known funding amount: 19,800,000 USD
Funding types: Shareholder Investment
Industry: Security
Market status: On the market
Organization type(s): Public Company
Product categories: Forensic Tagging
Production process: Closed Production
Source: NASEM Database
Trading symbol: APDN (NASDAQ)
Value chain stage: Finished Product
Spear-T Liquid Concentrate by Venter Institute + Vestaron
Biotech components: Gene Editing + Molecule + Yeast
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/17 11:00 (3 years ago)
Date last modified: 2019/09/17 11:00 (3 years ago)
Known funding amount: N/A
Funding types: Private Funding + Shareholder Investment
Industry: Food & Agriculture
Market status: On the market
Organization type(s): Public Company
Product categories: Chemical + Plant
Production process: N/A
Source: N/A
Trading symbol: N/A
Value chain stage: Finished Product
Succinic Acid by Myriant + Royal DSM + BioAmber, Inc.
Biotech components: Molecule
Business models: B2C
Country of production: USA
Country of distribution: N/A
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2018/11/08 14:37 (4 years ago)
Known funding amount: 155,600,000 USD
Funding types: Shareholder Investment
Industry: Food & Agriculture + Health + Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Additive + Chemical + Personal Care (Topical)
Production process: Closed Production
Source: SynBio Database
Trading symbol: BIOA (NYSE)
Value chain stage: Input
SYN-005 by Synthetic Biologics + Intrexon
Biotech components: Molecule
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2018/10/01 09:27 (4 years ago)
Known funding amount: 24,800,000 USD
Funding types: Shareholder Investment
Industry: Health
Market status: Under Development
Organization type(s): Public Company
Product categories: Medical Treatment
Production process: Closed Production
Source: Web search
Trading symbol: SYN (NYSEMKT)
Value chain stage: Finished Product
Synthorin™ Protein by Synthorx + Scripps Research Institute
Biotech components: Molecule
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Research
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2018/08/30 11:49 (4 years ago)
Known funding amount: 79,000,000 USD
Funding types: Venture Capital
Industry: Health
Market status: Under Development
Organization type(s): Private Company
Product categories: Medical Treatment
Production process: Open Release
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Finished Product
TALEN by Cellectis
Biotech components: Molecule
Business models: B2B
Country of production: USA + France
Country of distribution: USA + France
Intended consumer: Research
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2018/08/30 11:49 (4 years ago)
Known funding amount: 17,400,000 EUR
Funding types: Shareholder Investment
Industry: Health + Multipurpose
Market status: On the market
Organization type(s): Public Company
Product categories: Research
Production process: Closed Production
Source: Web search
Trading symbol: CLLS, ALCLS (NASDAQ, EPA)
Value chain stage: Platform
Biotech components: Molecule
Business models: B2C
Country of production: UK
Country of distribution: UK
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (4 years ago)
Date last modified: 2018/08/30 11:49 (4 years ago)
Known funding amount: N/A
Funding types: Private Funding
Industry: Security
Market status: On the market
Organization type(s): Private Company
Product categories: Forensic Tagging
Production process: Closed Production
Source: NASEM Database
Trading symbol: N/A
Value chain stage: Finished Product